Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — September 2016

Planlagt Fastgjort Låst Flyttet Genmab
2.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • bongobobB Offline
    bongobobB Offline
    bongobob
    wrote on sidst redigeret af
    #1862

    Der er lidt dødt lige nu så mens vi venter på en ny aftale fra Jan er her en lille nyhed. Dara safety study i Japan har resultater

    1 Reply Last reply
    0
    • bongobobB Offline
      bongobobB Offline
      bongobob
      wrote on sidst redigeret af
      #1863

      favicon

      (filehosting.pharmacm.com)

      1 Reply Last reply
      0
      • bongobobB Offline
        bongobobB Offline
        bongobob
        wrote on sidst redigeret af
        #1864

        Kun 9 patienter: "The ORR (sCR, CR, VGPR, and PR) was 25.0% (1 of 4 subjects) in the 8 mg/kg level and 60.0% (3 of
        5 subjects) in the 16 mg/kg level; all 4 subjects with ORR achieved a PR"

        1 Reply Last reply
        0
        • K Offline
          K Offline
          KWC
          wrote on sidst redigeret af
          #1865

          Tak

          1 Reply Last reply
          0
          • bongobobB Offline
            bongobobB Offline
            bongobob
            wrote on sidst redigeret af
            #1866

            Man kan jo sige det åbner op for det asiatiske marked, er der nogen der ved hvordan man får godkendelse i Japan?

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #1867

              Link Preview Image
              What’s the Drug Approval Process in Japan?

              The drug approval process in Japan includes a sequence of non-clinical studies, clinical studies followed by approval review, and post-marketing surveillance.

              favicon

              Market Realist (marketrealist.com)

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #1868

                Ups Kyprolis failer http://finance.yahoo.com/news/amgens-multiple-myeloma-drug-falls-091312097.html

                1 Reply Last reply
                0
                • K Offline
                  K Offline
                  KWC
                  wrote on sidst redigeret af
                  #1869

                  Det var pokkers 🙂

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #1870

                    Amgens $10 bn indkøb i problemer !

                    1 Reply Last reply
                    0
                    • O Offline
                      O Offline
                      OHW
                      wrote on sidst redigeret af
                      #1871

                      UPS!!

                      1 Reply Last reply
                      0
                      • Legolas23L Offline
                        Legolas23L Offline
                        Legolas23
                        wrote on sidst redigeret af
                        #1872

                        Øjs - kombien med kemo. Surt for dem. Bivirkningsmæssig må det også være kradse sager.

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          pauly
                          wrote on sidst redigeret af
                          #1873

                          man skal passe på med hvad man skriver, men våger det ene øje og mener vi da klarer os fint i dagens sure marked 🙂

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            pauly
                            wrote on sidst redigeret af
                            #1874

                            hov havde ikke set det japanske, det er da fine nyheder. Skal den så gennem hele møllen her? Fase 1-2-3 osv?

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              pauly
                              wrote on sidst redigeret af
                              #1875

                              det ser sådan ud ja. Ting tager tid

                              1 Reply Last reply
                              0
                              • G Offline
                                G Offline
                                gentogen
                                wrote on sidst redigeret af
                                #1876

                                http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-newsArticle&ID=2206091. Fatal treatment-emergent adverse events occurred in 6.5 percent of KMP patients !

                                1 Reply Last reply
                                0
                                • G Offline
                                  G Offline
                                  gentogen
                                  wrote on sidst redigeret af
                                  #1877

                                  The incidence of Grade 3 or higher adverse events was 74.7

                                  1 Reply Last reply
                                  0
                                  • J Offline
                                    J Offline
                                    Jedi
                                    wrote on sidst redigeret af
                                    #1878

                                    Der er dog også høj forekomst af Grade 3 or higher adverse events i VMP kontrolarmen: 76.2%

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      Jedi
                                      wrote on sidst redigeret af
                                      #1879

                                      Men sikke et tilbageslag for Amgen - Kyprolis er endnu ikke godkendt i front line, og dette kan vel betyde, at Kyprolis fremover kun vil blive brugt i 2. linje og senere hvor det har vist sig mere effektivt end Velcade

                                      1 Reply Last reply
                                      0
                                      • J Offline
                                        J Offline
                                        Jedi
                                        wrote on sidst redigeret af
                                        #1880

                                        På basis af dette vil lægerne jo også fremover vælge Velcade frem for Kyprolis til frontline behandling baseret på et PI regimen, som vel også er den billigste behandling

                                        1 Reply Last reply
                                        0
                                        • Legolas23L Offline
                                          Legolas23L Offline
                                          Legolas23
                                          wrote on sidst redigeret af
                                          #1881

                                          Det vil vel også stille Darzalex bedre i og med de har en bedre bivirkningsprofil, samt det er billigere. Det må være godt nyt for Dara i jagten på 1. linie !

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger